Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
Carlsmed Inc.

CARL

$8.89Jul 23, 2025 – Apr 30, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$283M
MVM
-$9.4M
BLE
-0.314
PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Chart Start
$14.50
2025
Since 2025
-38.7%
vs SPY +12.7%
All-time High
$17.19 · Dec 2025
-48.3% from peak
MVM Rank
#159 of 192
Health Care Equipment
Reaction Win Rate
60%
18 of 30 events

Carlsmed Inc. has returned -38.7% from $14.50 since 2025, trailing SPY's +12.7% over the same period. The stock hit an all-time high of $17.19 in Dec 2025 and is currently 48.3% below that level. Of 30 tracked news events, 60% produced a positive market-adjusted return.

How to use this page
1Company Research Snapshot

Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.

2Company Q&A

Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.

3News & Events

Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.

Company Q&AShow ▼
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-02-26+17.0%earningsMarketBeatCarlsmed Q4 Earnings Call Highlights
2026-02-26+17.0%earningsGuruFocus.comCarlsmed Inc (CARL) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...
2026-02-26+17.0%earningsSeeking AlphaCarlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M
2026-02-26+17.0%earningsSeeking AlphaCarlsmed targets $70M–$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook
2026-02-26+17.0%earningsSeeking AlphaCarlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript
2026-04-13+14.6%newsMarketBeatCarlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf
2025-11-06+13.9%earningsSeeking AlphaCarlsmed, Inc. GAAP EPS of -$0.40 beats by $0.02, revenue of $13.1M beats by $1.72M
2026-01-12+12.5%earningsSeeking AlphaCarlsmed Reports Q4, FY 2025 revenue above estimate
2026-02-25+11.2%newsGlobeNewswireCarlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-25+11.2%earningsChartMillCarlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
2026-04-14+10.9%newsGlobeNewswireCarlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
2026-04-28-9.9%newsGlobeNewswireCarlsmed, Inc. To Participate in Upcoming Investor Conferences
2025-11-29-7.5%newsSeeking AlphaCarlsmed: Back To Where We Started
2025-11-29-7.5%newsSeeking AlphaCarlsmed Stock: Back To Where We Started (NASDAQ:CARL) - Seeking Alpha
2025-08-18-7.0%newsSeeking AlphaCarlsmed initiated with Buy at Truist on business potential
2026-04-22-6.9%earningsCổng thông tin điện tử tỉnh Lào CaiCarlsmed (CARL) Stock Outlook | Q4 2025: Profit Exceeds Views - Expert Market Insights - Cổng thông tin điện tử tỉnh Lào Cai
2026-04-01+6.7%newsGlobeNewswireCarlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
2026-04-01+6.7%newsXã Thanh HàCARL Stock Analysis: Carlsmed Inc medical tech gains 6.41 percent trading at 9.63 - Xã Thanh Hà
2025-11-07+4.4%earningsSeeking AlphaCarlsmed, Inc. (CARL) Q3 2025 Earnings Call Transcript
2025-08-28-4.1%earningsSeeking AlphaCarlsmed, Inc. reports Q2 results
2025-12-27-3.6%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Carlsmed, Inc. (CARL) - Zacks Investment Research
2026-02-23+2.6%newsGlobeNewswireCarlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
2025-09-22+2.1%earningsSeeking AlphaCarlsmed joins Russell 2000 Index following Q3 IPO
2025-09-14-1.5%analyst富途牛牛Goldman Sachs highlights two high-potential stocks: AI marketing platform Braze (BRZE.US) and medical technology company Carlsmed (CARL.US), assigning them a 'Buy' rating. - 富途牛牛
2026-03-07-1.4%earningsMarketBeatCarlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference
2026-04-15+1.3%earningsMT NewswiresTruist Lowers Price Target on Carlsmed to $18 From $20, Keeps Buy Rating
2026-04-16-1.2%newsCổng thông tin điện tử Tỉnh Sơn LaCarlsmed (CARL) Stock: Why Market Expansion (Slight Loss) 2026-04-16 - Trending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La
2025-07-24-0.5%newsSeeking AlphaCarlsmed: Spine Play Does Not Have My Backing Yet
2025-07-24-0.5%newsSeeking AlphaCarlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha
2025-07-28+0.3%newsSan Diego Business JournalCarlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
2025-07-23—newsSeeking AlphaAI medtech firm Carlsmed prices $100.5M IPO
2025-07-23—newsNasdaqCarlsmed, Inc Rings the Opening Bell - Nasdaq
2025-07-23—newsfox5sandiego.comCarlsbad-based medical technology company begins trading on Nasdaq - fox5sandiego.com
2025-07-23—newsBloomberg.comAI Spine Surgery Firm Carlsmed Shares Fall 3.3% After IPO - Bloomberg.com
2025-07-23—newsBusiness WireCarlsmed Announces Pricing of Initial Public Offering - Business Wire
tickerdossier.comtickerdossier.substack.com